www.fdanews.com/articles/122431-raptor-pain-relief-compound-proves-effective-in-trial
Raptor: Pain Relief Compound Proves Effective in Trial
November 23, 2009
Development stage biotechnology company Raptor Pharmaceuticals Corp. said that its orally administered pain relief compound NGX426 proved effective in
a variety of neuropathic pain states, citing positive data from a clinical trial.
RTTNews
RTTNews